Podcast Episodes

Back to Search
From the Boston Globe's "Say More": What Happens When AI Decides Your Medical Coverage

This week, STAT's Casey Ross and Bob Herman joined the Boston Globe's "Say More" podcast to talk about their reporting on AI and Healthcare. We're sh…

2 years, 2 months ago

Short Long
View Episode
319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides

It's a guest-free episode this week, giving Allison, Adam and Elaine ample time to chat about the management shakeup at BioMarin, including the annou…

2 years, 2 months ago

Short Long
View Episode
318: Drug pricing drops & psychedelics under fire

STAT’s chief Washington correspondent Rachel Cohrs Zhang joins us to discuss the discounts and how this first round of negotiations between pharmaceu…

2 years, 2 months ago

Short Long
View Episode
317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision

STAT's Washington Correspondent John Wilkerson joins us to discuss the first round of drug pricing negotiations under the Inflation Reduction Act, wh…

2 years, 2 months ago

Short Long
View Episode
316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates

Andrew Joseph, STAT's Europe correspondent, joins us to talk about his special report on the 40-year quest to develop the world's first malaria vacci…

2 years, 2 months ago

Short Long
View Episode
315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves

What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math?

We discuss all tha…

2 years, 2 months ago

Short Long
View Episode
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages

Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health…

2 years, 3 months ago

Short Long
View Episode
313: Biotech layoffs, founder-focused VC, & a big pharma exit

STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Boris…

2 years, 3 months ago

Short Long
View Episode
312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate

STAT health tech reporter Brittany Trang guest co-hosts "The Readout LOUD" this week, where we discuss AI for drug development, the latest in the H5N…

2 years, 3 months ago

Short Long
View Episode
311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review

STAT reporter Jason Mast joins us to discuss Anthony Fauci's memoir "On Call," which was published this week. Hosts Allison DeAngelis and Adam Feuers…

2 years, 4 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us